Product Name
Park6 (PINK1), Polyclonal Antibody
Full Product Name
Park6 (PINK1) Antibody (C-term)
Product Synonym Names
Serine/threonine-protein kinase PINK1; mitochondrial; BRPK; PTEN-induced putative kinase protein 1; PINK1
Product Gene Name
anti-PINK1 antibody
[Similar Products]
Antibody/Peptide Pairs
Park6 (PINK1) peptide (MBS9226089) is used for blocking the activity of Park6 (PINK1) antibody (MBS9211262)
Research Use Only
For Research Use Only. Not for use in diagnostic procedures.
Immunogen Sequence Positions
493-526
3D Structure
ModBase 3D Structure for Q9BXM7
Species Reactivity
Human, mouse
Specificity
This Park6(PINK1) antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 493-526 amino acids from the C-terminal region of human Park6(PINK1).
Purity/Purification
Purified Rabbit Polyclonal Antibody (Pab)
Form/Format
Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is purified through a protein A column, followed by peptide affinity purification.
Antigen Type
Synthetic Peptide
Preparation and Storage
Maintain refrigerated at 2-8 degree C for up to 6 months. For long term storage store at -20 degree C in small aliquots to prevent freeze-thaw cycles.
Other Notes
Small volumes of anti-PINK1 antibody vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.
Related Product Information for
anti-PINK1 antibody
Parkinson is the second most common neurodegenerative disease after Alzheimers. About 1 percent of people over the age of 65 and 3 percent of people over the age of 75 are affected by the disease. The mutation is the most common cause of Parkinson disease identified to date. Defects in PINK1 are the cause of autosomal recessive early-onset Parkinson's disease 6 (PARK6). Six novel pathogenic PINK1 mutations suggest that PINK1 may be the second most common causative gene next to parkin in parkinsonism with the recessive mode of inheritance. Strong evidence indicates that, although important in mendelian forms of Parkinson's disease (PD), PINK1 does not influence the cause of sporadic nonmendelian forms of PD.
Product Categories/Family for anti-PINK1 antibody
Cardiovascular; Metabolism; Neuroscience; Signal Transduction
Applications Tested/Suitable for anti-PINK1 antibody
Western Blot (WB), ELISA (EIA)
Application Notes for anti-PINK1 antibody
WB~~1:1000
Western Blot (WB) of anti-PINK1 antibody
Western blot analysis of Park6 (PINK1) C-term in mouse kidney tissue lysates (35ug/lane). Park6 (arrow) was detected using the purified Pab.

NCBI/Uniprot data below describe general gene information for PINK1. It may not necessarily be applicable to this product.
NCBI Accession #
NP_115785.1
[Other Products]
NCBI GenBank Nucleotide #
NM_032409.2
[Other Products]
UniProt Primary Accession #
Q9BXM7
[Other Products]
UniProt Secondary Accession #
Q8N6T9; Q8NBU3; Q96DE4[Other Products]
UniProt Related Accession #
Q9BXM7[Other Products]
NCBI Official Full Name
serine/threonine-protein kinase PINK1, mitochondrial
NCBI Official Synonym Full Names
PTEN induced putative kinase 1
NCBI Official Symbol
PINK1??[Similar Products]
NCBI Official Synonym Symbols
BRPK; PARK6
??[Similar Products]
NCBI Protein Information
serine/threonine-protein kinase PINK1, mitochondrial
UniProt Protein Name
Serine/threonine-protein kinase PINK1, mitochondrial
UniProt Synonym Protein Names
BRPK; PTEN-induced putative kinase protein 1
Protein Family
Serine/threonine-protein kinase
UniProt Gene Name
PINK1??[Similar Products]
UniProt Entry Name
PINK1_HUMAN
NCBI Summary for PINK1
This gene encodes a serine/threonine protein kinase that localizes to mitochondria. It is thought to protect cells from stress-induced mitochondrial dysfunction. Mutations in this gene cause one form of autosomal recessive early-onset Parkinson disease. [provided by RefSeq, Jul 2008]
UniProt Comments for PINK1
PINK1: Protects against mitochondrial dysfunction during cellular stress, potentially by phosphorylating mitochondrial proteins. Involved in the clearance of damaged mitochondria via selective autophagy (mitophagy). It is necessary for PARK2 recruitment to dysfunctional mitochondria to initiate their degradation. Interats with PARK2. Highly expressed in heart, skeletal muscle and testis, and at lower levels in brain, placenta, liver, kidney, pancreas, prostate, ovary and small intestine. Present in the embryonic testis from an early stage of development. Belongs to the protein kinase superfamily. Ser/Thr protein kinase family. 2 isoforms of the human protein are produced by alternative splicing.
Protein type: Membrane protein, integral; Mitochondrial; Protein kinase, Ser/Thr (non-receptor); Protein kinase, Other; EC 2.7.11.1; Kinase, protein; Other group; NKF2 family
Chromosomal Location of Human Ortholog: 1p36
Cellular Component: mitochondrion; mitochondrial intermembrane space; cytosol; mitochondrial outer membrane; cytoskeleton; membrane; perinuclear region of cytoplasm; axon; mitochondrial inner membrane; cytoplasm; TORC2 complex; nucleus; chromatin; integral to mitochondrial outer membrane
Molecular Function: protein kinase B binding; protein serine/threonine kinase activity; protein binding; protease activator activity; protease binding; ubiquitin protein ligase binding; magnesium ion binding; kinase activity; ATP binding
Biological Process: ubiquitin-dependent protein catabolic process; positive regulation of dopamine secretion; negative regulation of JNK cascade; positive regulation of translation; regulation of protein ubiquitination; protein ubiquitination; protein amino acid phosphorylation; positive regulation of protein amino acid dephosphorylation; negative regulation of macroautophagy; regulation of mitochondrial membrane potential; positive regulation of ubiquitin-protein ligase activity; response to stress; regulation of protein complex assembly; negative regulation of neuron apoptosis; regulation of hydrogen peroxide metabolic process; mitochondrion organization and biogenesis; positive regulation of I-kappaB kinase/NF-kappaB cascade; protein stabilization; activation of protein kinase B; positive regulation of synaptic transmission, dopaminergic; positive regulation of peptidyl-serine phosphorylation; positive regulation of protein kinase B signaling cascade; peptidyl-serine phosphorylation; mitochondrion degradation; positive regulation of transcription factor activity; positive regulation of protein amino acid phosphorylation; response to oxidative stress; phosphorylation
Disease: Parkinson Disease 6, Autosomal Recessive Early-onset
Product References and Citations for anti-PINK1 antibody
Hatano, Y., et al., Ann. Neurol. 56(3):424-427 (2004).
Healy, D.G., et al., Ann. Neurol. 56(3):329-335 (2004).
Valente, E.M., et al., Science 304(5674):1158-1160 (2004).
Nakajima, A., et al., Cancer Lett. 201(2):195-201 (2003).
Unoki, M., et al., Oncogene 20(33):4457-4465 (2001).
Research Articles on PINK1
1. PINK1 has tumor-promoting properties and PINK1 functions as a regulator of the cell cycle.
Precautions
All of MyBioSource's Products are for scientific laboratory research purposes and are not for diagnostic, therapeutics, prophylactic or in vivo use. Through your purchase, you expressly represent and warrant to MyBioSource that you will properly test and use any Products purchased from MyBioSource in accordance with industry standards. MyBioSource and its authorized distributors reserve the right to refuse to process any order where we reasonably believe that the intended use will fall outside of our acceptable guidelines.
Disclaimer
While every efforts were made to ensure the accuracy of the information provided in this datasheet, MyBioSource will not be liable for any omissions or errors contained herein. MyBioSource reserves the right to make changes to this datasheet at any time without prior notice.
It is the responsibility of the customer to report product performance issues to MyBioSource within 30 days of receipt of the product. Please visit our Terms & Conditions page for more information.